Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis
NCT01268956 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2011-01-04
Summary
Correlation of circulating lymphatic endothelial progenitor cells with lymph node metastasis
Conditions
Sponsors & Collaborators
-
Hospital Universitari de Bellvitge
lead OTHER
Principal Investigators
-
Pianyifan pianyifan, Doctor · Southwest Hospital, China
Eligibility
- Min Age
- 15 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-09-30
Countries
- China
More Related Trials
-
Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
NCT06853730 ·Status: COMPLETED
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4
NCT02326064 ·Status: COMPLETED
-
Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study
NCT05592925 ·Status: UNKNOWN
-
Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
NCT01258881 ·Status: UNKNOWN
-
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
NCT02436772 ·Status: COMPLETED
-
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
NCT05285579 ·Status: UNKNOWN
-
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
NCT01374672 ·Status: COMPLETED
-
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
NCT03017573 ·Status: RECRUITING ·Phase: NA
-
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
NCT03614689 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
NCT02948946 ·Status: COMPLETED
-
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
NCT06564428 ·Status: RECRUITING
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA
-
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
NCT05769517 ·Status: RECRUITING
-
Establishment of a Prospective Clinical-biological Database
NCT04458792 ·Status: RECRUITING ·Phase: NA
-
New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence
NCT05410028 ·Status: RECRUITING
-
MRI and Metabolomics Biomarkers for Uterine Malignancy
NCT02528864 ·Status: COMPLETED
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
NCT00898781 ·Status: TERMINATED
-
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06689956 ·Status: RECRUITING
-
Analysis of Biomarkers in Lymph Node Tissue
NCT04228796 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors
NCT02586844 ·Status: COMPLETED
-
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.
NCT02789384 ·Status: RECRUITING ·Phase: NA
-
Molecular Markers in Treatment in Endometrial Cancer
NCT00598845 ·Status: UNKNOWN
-
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
NCT00155896 ·Status: UNKNOWN